Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Alamar Biosciences, Inc.NASDAQ: ALMR

Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Financing cash flow of $201.84M in Q2 FY2026

Q2 FY2026 financing cash flow was $201.84M.

Context

  • Financing cash flow amounted to 14.6% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$201.84M+262.0% QoQ
Last fiscal yearDec 2025
$10.84M— YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
10.84M USD
Year-over-year change
—

Financing Cash Flow vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 financing cash flow of $10.84M is the 5th largest of the 9 companies compared; the peer median is $938.5K.
  • Financing cash flow amounts to 14.6% of revenue for ALMR, versus a peer median of 8.8%.
ALMR Competitors Peer median
Financing Cash Flow for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TWSTTwist Bioscience CorporationLTM Sep 2026$446.68M +1465.1%+688.5%97.2%
TECHBio-Techne CorporationLTM Sep 2026$108.53M -62.1%—8.8%
QSIQuantum-Si incorporatedLTM Mar 2026$47.05M -44.2%+268.4%2540.4%
SEERSeer, Inc.LTM Mar 2026$11.67M -10.2%—77.6%
ALMRAlamar Biosciences, Inc.FY2025$10.84M ——14.6%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$2.91M +106.1%-29.1%1.8%
TXG10x Genomics, Inc.LTM Jun 2026$2.54M -129.5%-24.5%0.4%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$1.3M +41.9%-27.5%—
LABStandard BioTools Inc.LTM Mar 2026$576K +100.7%-86.5%0.7%
Peer median (excluding ALMR) $938.5K+15.8%-26.0%8.8%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.